3,107
Views
10
CrossRef citations to date
0
Altmetric
Coronavirus – Case Report

Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2059308 | Received 30 Jan 2022, Accepted 22 Mar 2022, Published online: 06 Apr 2022

References

  • Havers FP, Whitaker M, Self JL, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Meek J, Yousey-Hindes K, Anderson EJ, et al. Hospitalization of adolescents aged 12–17 years with laboratory-confirmed COVID-19 — COVID-NET, 14 states, March 1, 2020–April 24, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(23):851–6. doi:10.15585/mmwr.mm7023e1.
  • U.S. Food and Drug Administration. FDA authorizes Pfizer-BioNtech COVID-19 vaccine for emergency use in children 5 through 11 years of age. 2021 [accessed 2022 January 28]. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age.
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15. doi:10.1056/NEJMoa2034577.
  • Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021;385(3):239–50. doi:10.1056/NEJMoa2107456.
  • Jain SS, Steele JM, Fonseca B, Huang S, Shah S, Maskatia SA, Buddhe S, Misra N, Ramachandran P, Gaur L, et al. COVID-19 vaccination–associated myocarditis in adolescents. Pediatrics. 2021;148(5):e2021053427. doi:10.1542/peds.2021-053427.
  • Marshall M, Ferguson ID, Lewis P, Jaggi P, Gagliardo C, Collins JS, Shaughnessy R, Caron R, Fuss C, Corbin KJE, et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNtech COVID-19 vaccination. Pediatrics. 2021;148(3):e2021052478. doi:10.1542/peds.2021-052478.
  • Korea Centers for Disease Control and Prevention (KCDC). Status of monitoring adverse events after vaccination against COVID-19 for adolescents (12-17 years old). Public Health Wkly Rep. 2021;14:3542–48.
  • Bomback AS, Kudose S, D’-Agati VD. De Novo and relapsing glomerular diseases after COVID-19 vaccination: what do we know so far? Am J Kidney Dis. 2021;78(4):477–80. doi:10.1053/j.ajkd.2021.06.004.
  • Lebedev L, Sapojnikov M, Wechsler A, Varadi-Levi R, Zamir D, Tobar A, Levin-Iaina N, Fytlovich S, Yagil Y. Minimal change disease following the Pfizer-BioNtech COVID-19 vaccine. Am J Kidney Dis. 2021;78(1):142–45. doi:10.1053/j.ajkd.2021.03.010.
  • Tan HZ, Tan RY, Choo JCJ, Lim CC, Tan CS, Loh AHL, Tien CSY, Tan PH, Woo KT. Is COVID-19 vaccination unmasking glomerulonephritis? Kidney Int. 2021;100(2):469–71. doi:10.1016/j.kint.2021.05.009.
  • Mira FS, Carvalho JC, de Almeida PA, Pimenta AC, Coutinho IA, Figueiredo C, Rodrigues L, Sousa V, Ferreira E, Pinto H, et al. A case of acute interstitial nephritis after two doses of the BNT162b2 SARS-CoV-2 vaccine. Int J Nephrol Renovasc Dis. 2021;14:421–26. doi:10.2147/IJNRD.S345898.
  • Nakazawa E, Uchimura T, Hirai Y, Togashi H, Oyama Y, Inaba A, Shiga K, Ito S. New-Onset pediatric nephrotic syndrome following Pfizer-BioNtech SARS-CoV-2 vaccination: a case report and literature review. CEN Case Rep. 2021:1–5. Online ahead of print. doi:10.1007/s13730-021-00656-0.
  • Hanna C, Herrera Hernandez LP, Bu L, Kizilbash S, Najera L, Rheault MN, Czyzyk J, Kouri AM. IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney Int. 2021;100(3):705–06. doi:10.1016/j.kint.2021.06.032.